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Introduction
            Implantable cardioverter defibrillators (ICD) are state of the art devices for the primary 
and secondary prevention of sudden cardiac death.1 As a result, the use of ICDs has increased 
remarkably over the past years. Since they are life saving devices and because dysfunction can 
cause fatal pro-arrhythmia2, monitoring of their proper functioning is vital for patient welfare.
            To date, conventional ICD follow-up is in the form of device clinics where the ICD is 
interrogated and programmed periodically and the appropriate system function is ensured. 
Remote device monitoring has recently been introduced and may provide advantages especially 
for patients living further away from the implanting center.3 Another important feature of current 
ICDs is the ability to monitor the device function and the patient clinical status, and to alert the 
patient if evidence for system dysfunction or adverse clinical events is found. This article gives 
an overview about patient alerting features of current ICDs.                                                     
Alert features related to device function                                                                   
               Programming a ventricular fibrillation (VF) detection zone with shock therapy is 
essential for adequate ICD function. To ensure this condition, an alert may be triggered if VF 
detection   and   /   or   three   or   more   VF   therapies   are   programmed   off   by   mistake.
            ICD battery longevity is limited and capacitor charging times increase prior to battery 
depletion. Thus, it is important to exchange the device in time (when the recommended 
replacement time is reached). Currently available alert features warn the patient in case of low 
battery voltage and / or because of excessive capacitor charge time.4                                                                 
            Lead-related adverse events occur in a small but significant proportion of ICD patients4,5 
and will probably become more frequent in the future since a growing amount of leads remains 
in place when generators are replaced for battery depletion. ICD lead failure may cause 
ineffective treatment during ventricular arrhythmia or inappropriate therapy due to oversensing 
of electrical noise.5,6 Thus, early detection of ICD lead dysfunction, ideally prior to an adverse 
clinical event, is essential. Alert features that monitor lead impedance can enhance the  early 
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detection of ICD lead failure.4,5,7 Devices with this feature deliver sub-threshold impulses on a 
daily basis to determine the impedance within the pace-sense or high voltage circuit of the ICD 
lead.5,8 A very low lead impedance may indicate insulation failure, while a very high impedance 
may indicate conductor fracture. The upper and lower alert boundaries may be programmable, 
but typically a pacing lead impedance <200 or >2,500 to 3000 Ω and high-voltage lead 
impedance   <10   to   20   or   >200   Ω   is   considered   abnormal   and   will   trigger   an   alert.
            Furthermore, an alert may be triggered if anywhere from one to six high voltage shocks 
occur during one single episode or if all device therapies within one tachycardia detection zone 
are   delivered.   Both   of   these   alerts   may   indicate   device   dysfunction   (e.g.,   ventricular 
oversensing) or a clinical problem like an incessant VT or atrial fibrillation with rapid 
atrioventricular   conduction.                                                              
Alert features related to patient clinical status                                                       
               Most   ICD   patients   are   also   at   risk   for   clinical   events   other   than   ventricular 
tachyarrhythmias. The so-called OptiVol™ alert feature is based on intrathoracic impedance 
monitoring   and   has   been   introduced   in   an   effort   to   enhance   the   early   detection   of  
decompensating chronic heart failure (CHF).9 Observational data suggest that this alert feature 
can   be   integrated   into   the   ambulatory   management   of   CHF   patients.9                       
            Other alert features are related to the occurrence of atrial tachyarrhythmias. An alert that 
warns the patient if the daily atrial tachyarrhythmia burden exceeds a programmable value may 
help to prevent thrombembolic events.11  Another alert feature is triggered if the average 
ventricular rate during an atrial tachyarrhythmia episode crosses a programmable threshold, 
thereby preventing high ventricular rates that may lead to CHF decompensation.                      
 
Limitations of current alert features and future perspective                                           
            There is a broad variation in the availability of alert features between ICD models from 
different manufacturers. Most of the existing alert features are available in recent Medtronic 
ICDs. In these devices, the patient can be alerted by an audible signal, occurring once daily at a 
programmable time. The limitation of using an acoustic signal is that some patients may not hear 
the alert, while other subjects may confuse environmental noise with the device alert tone. This 
can result in "phantom alerts" that cannot be verified upon ICD interrogation. To overcome these 
limitations, an external device (available in Europe) that provides wireless communication with 
the implanted ICD can be handed out to these subjects. In case of an alert event, patients are then 
visually warned (signal light on). In recent devices from St. Jude Medical, vibration of the ICD 
is used to alert the patient of potential device dysfunction. One limitation of acoustic, visual and 
tactile alerts is that the patient has to contact the physician first to allow an intervention. Recent 
devices offer automatic remote transmission of alert events and associated diagnostic data, 
which may allow a more rapid event verification and intervention by the physician.               
 
            Despite obvious advantages, patient alerting features do not yet substitute for regular 
follow-up visits. In particular, current alert algorithms have only a limited sensitivity to detect 
lead-related problems.4,5  Lead dislocation may not be detected because pacing and sensing 
thresholds are not monitored. Impending ICD lead failure is often not detected sufficiently early, 
because sporadic measurements of impedance (once daily) are unlikely to reveal unusual 
findings if the structural lead defect is discrete at first and electrical integrity is lost only for brief 
moments (e.g. during arm movement). Continuous monitoring of lead integrity can be achieved 
by the Sensing Integrity Counter (SIC, Medtronic), which is a cumulative count of very short 
ventricular senses intervals that indicate oversensing of electrical noise. Retrospective data 
suggest that the combined use of SIC and impedance monitoring would  result in very  high 
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sensitivity for ICD lead failure detection.5,12 Unfortunately, however, this feature has not yet 
been integrated into a patient alert algorithm.                                                                 
            Alert features that monitor the clinical status of ICD patients, e.g. for impending CHF 
decompensation or the onset of atrial tachyarrhythmias, are exciting new diagnostic tools that 
may improve patient management. However, it is not yet clear how these diagnostic data should 
be integrated into routine clinical practice, and if hard endpoints such as hospitalizations or 
mortality can be reduced. Large randomized controlled trials are on the way to answer these 
questions.
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